Showing 1671-1680 of 10595 results for "".
The Biggest Developments in Dermatology: Drs. Tsao and Friedlander Provide Updates at Maui Derm
https://practicaldermatology.com/issues/january-february-2025/the-biggest-developments-in-dermatology-drs-tsao-and-friedlander-provide-updates-at-maui-derm/32937/The development of new therapeutics for dermatologic conditions in recent years has been so prolific that Hensin Tsao, MD, PhD, adopted a “Maui Journal of Medicine” theme for his conference-opening presentation at the Maui Derm Hawaii 2025 meeting in Maui, Hawaii.AI in Derm: Applying New Tech to Your Practice
https://practicaldermatology.com/topics/practice-management/ai-in-derm-applying-new-tech-to-your-practice/24219/It is with great pleasure and enthusiasm that I begin this quarterly column dedicated to the intersection of dermatology and artificial intelligence (AI). I am a board-certified dermatologist currently pursuing a fellowship in Mohs surgery and cosmetic surgery at Northwestern University. As I embarkHarnessing AI for Dermatology Residents
https://practicaldermatology.com/issues/may-june-2025/harnessing-ai-for-dermatology-residents/35915/Dermatology residents face the dual challenge of delivering high-quality patient care while continually advancing their medical knowledge and research skills.How NEMLUVIO® Works
https://practicaldermatology.com/programs/nemluvio-peer-network/how-nemluvio-works/37226/Learn how NEMLUVIO® works to directly block IL-31RA from Dr Peter Lio, a leading dermatologist, with extensive experience in treating neuroimmune skin diseases.Can Vitamin B3 Reduce Recurrence of NMSC?
https://practicaldermatology.com/topics/practice-management/can-vitamin-b3-reduce-recurrence-of-nmsc/21165/A common OTC vitamin supplement shows early promise in preventing secondary NMSCs. Is it time to recommend it?A Highly Effective Topical Compounded Medication for the Treatment of Cutaneous Warts
https://practicaldermatology.com/topics/general-topics/a-highly-effective-topical-compounded-medication-for-the-treatment-of-cutaneous-warts/20583/A compounded formulation with an adhesive vehicle shows promise for one of the most common and frustrating conditions to treat in dermatology.Monitoring Biologic Therapy In Psoriasis: A Primer
https://practicaldermatology.com/topics/psoriasis/monitoring-biologic-therapy-in-psoriasis-a-primer/20931/Treatments are generally safe and well-tolerated, however, prescribers must monitor for risk factors.Attention, Please! Why Dermatologists Need to Confront Burnout
https://practicaldermatology.com/topics/practice-management/attention-please-why-dermatologists-need-to-confront-burnout/20557/Raising awareness of the problem is essential to finding a solution.DermWireTV: Qwo Approved, Assessing Resident Anxiety
https://practicaldermatology.com/videos/dermwire-tv/dermwiretv-qwo-approved-assessing-resident-anxiety/19830/FDA has approved Qwo (collagenase clostridium histolyticum-aaes) from Endo, the first injectable treatment approved for moderate to severe cellulite in the buttocks of adult women. A recent survey offers perspective on anxiety among third-year dermatology residents in light of the COVID crisis. AlleDermWire TV: Merz Reorganizes; Amzeeq Approved; Restoration Merges with Venus Concept
https://practicaldermatology.com/videos/dermwire-tv/dermwire-tv-merz-reorganizes-amzeeq-approved-restoration-merges-with-venus-concept/19694/Bob Rhatigan, newly appointed Global Chief Executive Officer of Merz Aesthetics, speaks about Merz reorganization. Amzeeq topical foam (Foamix Pharmaceuticals) approved for inflammatory, non-nodular, moderate to severe acne vulgaris in adults and pediatric patients 9 years of age and older. FD